Consonance Capital Management LP - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 171 filers reported holding ANI PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
Consonance Capital Management LP ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$10,418,000
-11.3%
142,9430.0%1.03%
+23.9%
Q2 2019$11,750,000
+16.5%
142,9430.0%0.83%
+30.8%
Q1 2019$10,083,000
+56.7%
142,9430.0%0.64%
+34.5%
Q4 2018$6,435,000
-20.4%
142,9430.0%0.47%
+8.7%
Q3 2018$8,082,000
-15.4%
142,9430.0%0.44%
-29.4%
Q2 2018$9,549,000
+14.7%
142,9430.0%0.62%
-18.9%
Q1 2018$8,322,000
-9.7%
142,943
-0.0%
0.76%
-8.7%
Q4 2017$9,215,000
+22.8%
142,978
-0.0%
0.83%
+0.2%
Q3 2017$7,506,000
+12.1%
143,0030.0%0.83%
+5.2%
Q2 2017$6,693,000
-5.5%
143,0030.0%0.79%
+6.3%
Q1 2017$7,080,000
-76.2%
143,003
-70.9%
0.74%
-77.3%
Q4 2016$29,801,000
-31.2%
491,608
-24.7%
3.27%
-21.5%
Q3 2016$43,344,000
-5.0%
653,258
-20.1%
4.17%
-35.4%
Q2 2016$45,630,000
+31.8%
817,456
-20.5%
6.46%
+23.3%
Q1 2016$34,615,000
-19.0%
1,028,364
+8.7%
5.24%
-8.6%
Q4 2015$42,710,000
+2.3%
946,489
-10.4%
5.73%
-2.4%
Q3 2015$41,734,000
-36.3%
1,056,289
+0.0%
5.87%
-10.8%
Q2 2015$65,512,000
-6.9%
1,055,791
-6.1%
6.58%
+2.7%
Q1 2015$70,348,000
+14.4%
1,124,667
+3.2%
6.41%
-19.1%
Q4 2014$61,469,000
+295.3%
1,090,067
+98.3%
7.92%
+271.0%
Q3 2014$15,549,000
+27.1%
549,827
+54.8%
2.13%
+17.3%
Q2 2014$12,236,000
+55.3%
355,276
+41.4%
1.82%
+55.3%
Q1 2014$7,877,000251,2631.17%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
AIGH Capital Management LLC 272,801$15,838,8267.50%
Global Alpha Capital Management Ltd. 525,528$30,512,1563.06%
Rubric Capital Management LP 847,011$49,177,4591.84%
Ranger Investment Management 426,848$24,782,7951.64%
Parkman Healthcare Partners LLC 111,802$6,491,2241.19%
MARATHON CAPITAL MANAGEMENT 71,670$4,161,1601.05%
Mesirow Financial Investment Management, Inc. 3,862$224,2280.98%
Deep Track Capital, LP 400,000$23,224,0000.90%
1492 Capital Management LLC 18,178$1,055,4150.68%
Phocas Financial Corp. 75,213$4,367,0000.64%
View complete list of ANI PHARMACEUTICALS INC shareholders